Astrid Gendolla - Concepedia

Author

Astrid Gendolla

Charité - Universitätsmedizin Berlin ORCID

Also Known As

A Gendolla, A. Gendolla, Astrid Gendolla, Gendolla A.

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Ludwig-Maximilians-Universität München Universitätsmedizin Greifswald University of Duisburg-Essen Migräne Klinik Königstein

About

Astrid Gendolla is an author at Charité - Universitätsmedizin Berlin specializing in neurology, medicine, and rehabilitation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	72
2	Neurology	3	3	72
3	Rehabilitation	2	2	46
4	Health Sciences	1	1	26
5	Brain Stimulation	1	1	21

Astrid Gendolla

Publications

Citations

H-Index

Page 1

	Year	Citations
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial Uwe Reuter, Marc Ehrlich, Astrid Gendolla, Cephalalgia	2021	157
Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study Lucas Hendrik Overeem, Andreas Peikert, Maxi Dana Hofacker, Cephalalgia	2021	118
Validity and Reliability of the Migraine-Treatment Optimization Questionnaire RB Lipton, Ken Kolodner, ME Bigal, Cephalalgia	2009	108
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study Bianca Raffaelli, Rea Kalantzis, Jasper Mecklenburg, Frontiers in Neurology	2020	88
Telmisartan in Migraine Prophylaxis: A Randomized, Placebo-Controlled Trial HC Diener, Astrid Gendolla, A Fruersenger, Cephalalgia	2009	75
Topiramate for Migraine Prevention in Adolescents: A Pooled Analysis of Efficacy and Safety Paul Winner, Astrid Gendolla, Catherine Stayer, Headache The Journal of Head and Face Pain	2006	60
Occipital nerve stimulation for chronic migraine: A randomized trial on subthreshold stimulation PJ Slotty, Gregor Bara, L Kowatz, Cephalalgia	2014	49
Almotriptan in Migraine Patients Who Respond Poorly to Oral Sumatriptan: A Double‐Blind, Randomized Trial Hans‐Christoph Diener, Astrid Gendolla, Irmingard Gebert, Headache The Journal of Head and Face Pain	2005	47
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study Raffaele Ornello, Carlo Baraldi, Simona Guérzoni, The Journal of Headache and Pain	2022	45
Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men Raffaele Ornello, Carlo Baraldi, Simona Guérzoni, Frontiers in Neurology	2021	28

Page 1